DNASE1 and cystic fibrosis: Dornase alfa (rhDNAse; 2.5 mg; once or twice daily) in nebulized form is useful in reducing the risk of exacerbations of respiratory symptoms requiring parenteral antibiotics in children with CF (COR: I, agreement, moderate to high COE).